David A. Siegel Guardant Health, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,177,300 shares of GH stock, worth $36.1 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,177,300
Previous 770,800
52.74%
Holding current value
$36.1 Million
Previous $22.3 Million
21.27%
% of portfolio
0.07%
Previous 0.05%
Shares
13 transactions
Others Institutions Holding GH
# of Institutions
323Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$359 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$345 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$311 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$213 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$184 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.14B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...